ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 131 filers reported holding ABCELLERA BIOLOGICS INC in Q1 2022. The put-call ratio across all filers is 0.31 and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $30,952,416 | -25.6% | 4,105,095 | 0.0% | 3.25% | -36.9% |
| Q4 2022 | $41,584,612 | +2.4% | 4,105,095 | 0.0% | 5.16% | +2.1% |
| Q3 2022 | $40,599,000 | -7.1% | 4,105,095 | 0.0% | 5.05% | -0.2% |
| Q2 2022 | $43,719,000 | +9.2% | 4,105,095 | 0.0% | 5.06% | +25.3% |
| Q1 2022 | $40,025,000 | -31.8% | 4,105,095 | 0.0% | 4.04% | -26.7% |
| Q4 2021 | $58,703,000 | -28.6% | 4,105,095 | 0.0% | 5.51% | +14.3% |
| Q3 2021 | $82,266,000 | -8.9% | 4,105,095 | 0.0% | 4.82% | -7.2% |
| Q2 2021 | $90,312,000 | -35.2% | 4,105,095 | 0.0% | 5.20% | -33.3% |
| Q1 2021 | $139,409,000 | -15.6% | 4,105,095 | 0.0% | 7.79% | -13.1% |
| Q4 2020 | $165,189,000 | – | 4,105,095 | – | 8.96% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $37,320,000 | 92.58% |
| Gruss & Co., LLC | 308,570 | $3,052,000 | 26.27% |
| Founders Fund Growth Management, LLC | 407,017 | $4,025,000 | 11.55% |
| Belmont Capital, LLC | 510,000 | $5,044,000 | 5.95% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $40,599,000 | 5.05% |
| GUARDIAN CAPITAL ADVISORS LP | 3,736,414 | $40,129,000 | 5.01% |
| Intellectus Partners, LLC | 1,091,505 | $10,795,000 | 3.84% |
| ArchPoint Investors | 617,213 | $6,104,000 | 2.49% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $563,000 | 1.85% |
| Casdin Capital, LLC | 1,650,000 | $16,319,000 | 1.07% |